BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35801250)

  • 1. Molecular Epidemiology of AY.28 and AY.104 Delta Sub-lineages in Sri Lanka.
    Ranasinghe D; Jayathilaka D; Jeewandara C; Gunasinghe D; Ariyaratne D; Jayadas TTP; Kuruppu H; Wijesinghe A; Bary FF; Madhusanka D; Pushpakumara PD; Guruge D; Wijayamuni R; Ogg GS; Malavige GN
    Front Public Health; 2022; 10():873633. PubMed ID: 35801250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India.
    Gupta N; Kaur H; Yadav PD; Mukhopadhyay L; Sahay RR; Kumar A; Nyayanit DA; Shete AM; Patil S; Majumdar T; Rana S; Gupta S; Narayan J; Vijay N; Barde P; Nataraj G; B AK; Kumari MP; Biswas D; Iravane J; Raut S; Dutta S; Devi S; Barua P; Gupta P; Borkakoty B; Kalita D; Dhingra K; Fomda B; Joshi Y; Goyal K; John R; Munivenkatappa A; Dhodapkar R; Pandit P; Devi S; Dudhmal M; Kinariwala D; Khandelwal N; Tiwari YK; Khatri PK; Gupta A; Khatri H; Malhotra B; Nagasundaram M; Dar L; Sheikh N; Shastri J; Aggarwal N; Abraham P
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Epidemiology of the Norwegian SARS-CoV-2 Delta Lineage AY.63.
    Moen LV; Vollan HS; Bråte J; Hungnes O; Bragstad K
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2.
    Saunders N; Planas D; Bolland WH; Rodriguez C; Fourati S; Buchrieser J; Planchais C; Prot M; Staropoli I; Guivel-Benhassine F; Porrot F; Veyer D; Péré H; Robillard N; Saliba M; Baidaliuk A; Seve A; Hocqueloux L; Prazuck T; Rey FA; Mouquet H; Simon-Lorière E; Bruel T; Pawlotsky JM; Schwartz O
    EBioMedicine; 2022 Mar; 77():103934. PubMed ID: 35290827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dynamics of circulating SARS-CoV-2 lineages in Bogor and surrounding areas reflect variant shifting during the first and second waves of COVID-19 in Indonesia.
    Prasetyoputri A; Dharmayanthi AB; Iryanto SB; Andriani A; Nuryana I; Wardiana A; Ridwanuloh AM; Swasthikawati S; Hariyatun H; Nugroho HA; Idris I; Indriawati I; Noviana Z; Oktavia L; Yuliawati Y; Masrukhin M; Hasrianda EF; Sukmarini L; Fahrurrozi F; Yanthi ND; Fathurahman AT; Wulandari AS; Setiawan R; Rizal S; Fathoni A; Kusharyoto W; Lisdiyanti P; Ningrum RA; Saputra S
    PeerJ; 2022; 10():e13132. PubMed ID: 35341058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2.
    Eales O; Page AJ; de Oliveira Martins L; Wang H; Bodinier B; Haw D; Jonnerby J; Atchison C; ; Ashby D; Barclay W; Taylor G; Cooke G; Ward H; Darzi A; Riley S; Chadeau-Hyam M; Donnelly CA; Elliott P
    BMC Infect Dis; 2022 Jul; 22(1):647. PubMed ID: 35896970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomics of postvaccination SARS-CoV-2 infections during the Delta dominated second wave of COVID-19 pandemic, from Mumbai Metropolitan Region (MMR), India.
    Nilgiriwala K; Kadam P; Patel G; Shaikh A; Mestry T; Vaswani S; Sakthivel S; Poojary A; Gandhi B; Rohra S; Udwadia Z; Oswal V; Shah D; Gomare M; Sriraman K; Mistry N
    J Med Virol; 2022 Sep; 94(9):4206-4215. PubMed ID: 35578378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial introduction and spread of the SARS-CoV-2 AY.4.2.1 Delta variant in Bulgaria, a genomic insight.
    Alexiev I; Giovanetti M; Cella E; Ivanov I; Stoikov I; Donchev D; Grigorova L; Gancheva A; Dimitrova R; Korsun N; Trifonova I; Philipova I; Dobrinov V; Grigorova I; Kantardjiev T; Christova I; Ciccozzi M
    J Med Virol; 2022 Dec; 94(12):6060-6064. PubMed ID: 35902787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralisation of the SARS-CoV-2 Delta variant sub-lineages AY.4.2 and B.1.617.2 with the mutation E484K by Comirnaty (BNT162b2 mRNA) vaccine-elicited sera, Denmark, 1 to 26 November 2021.
    Lassaunière R; Polacek C; Fonager J; Bennedbæk M; Boding L; Rasmussen M; Fomsgaard A
    Euro Surveill; 2021 Dec; 26(49):. PubMed ID: 34886943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Delta variant wave in Tunisia: Genetic diversity, spatio-temporal distribution and evidence of the spread of a divergent AY.122 sub-lineage.
    Haddad-Boubaker S; Arbi M; Souiai O; Chouikha A; Fares W; Edington K; Sims S; Camma C; Lorusso A; Diagne MM; Diallo A; Boubaker IBB; Ferjani S; Mastouri M; Mhalla S; Karray H; Gargouri S; Bahri O; Trabelsi A; Kallala O; Hannachi N; Chaabouni Y; Smaoui H; Meftah K; Bouhalila SB; Foughali S; Zribi M; Lamari A; Touzi H; Safer M; Alaya NB; Kahla AB; Gdoura M; Triki H
    Front Public Health; 2022; 10():990832. PubMed ID: 36684874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses.
    Kannan SR; Spratt AN; Cohen AR; Naqvi SH; Chand HS; Quinn TP; Lorson CL; Byrareddy SN; Singh K
    J Autoimmun; 2021 Nov; 124():102715. PubMed ID: 34399188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 genomic surveillance in Malaysia: displacement of B.1.617.2 with AY lineages as the dominant Delta variants and the introduction of Omicron during the fourth epidemic wave.
    Azami NAM; Perera D; Thayan R; AbuBakar S; Sam IC; Salleh MZ; Isa MNM; Ab Mutalib NS; Aik WK; Suppiah J; Tan KK; Chan YF; Teh LK; Azzam G; Rasheed ZBM; Chan JCJ; Kamel KA; Tan JY; Khalilur Rahman O; Lim WF; Johari NA; Ishak M; Yunos RIM; Anasir MI; Wong JE; Fu JYL; Noorizhab MNF; Sapian IS; Mokhtar MFM; Md Shahri NAA; Ghafar K; Yusuf SNHM; Noor YM; Jamal R;
    Int J Infect Dis; 2022 Dec; 125():216-226. PubMed ID: 36336246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology of SARS-CoV-2 variants in circulation in the state of Maranhão, Brazil.
    de Sousa LAF; Ferreira LSS; Lobato LFL; Ferreira HLDS; Sousa LHDS; Santos VFD; Nunes PRS; Maramaldo CEC; Neto SS; Sampaio HL; Silva FVD; Brito MDC; Lima WKR; Lima CZGPA; Neto LGL
    J Med Virol; 2023 Sep; 95(9):e29092. PubMed ID: 37724346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Emergence and Dispersal of Delta SARS-CoV-2 Lineage AY.99.2 in Brazil.
    Romano CM; de Oliveira CM; da Silva LS; Levi JE
    Front Med (Lausanne); 2022; 9():930380. PubMed ID: 35783651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic diversity of SARS-CoV-2 in Pakistan during the fourth wave of pandemic.
    Umair M; Ikram A; Rehman Z; Haider SA; Ammar M; Badar N; Ali Q; Rana MS; Salman M
    J Med Virol; 2022 Oct; 94(10):4869-4877. PubMed ID: 35754094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early introduction, dispersal and evolution of Delta SARS-CoV-2 in Southern Brazil, late predominance of AY.99.2 and AY.101 related lineages.
    Gularte JS; da Silva MS; Mosena ACS; Demoliner M; Hansen AW; Filippi M; Pereira VMAG; Heldt FH; Weber MN; de Almeida PR; Hoffmann AT; Valim ARM; Possuelo LG; Fleck JD; Spilki FR
    Virus Res; 2022 Apr; 311():198702. PubMed ID: 35104582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters.
    Mohandas S; Yadav PD; Shete A; Nyayanit D; Jain R; Sapkal G; Mote C
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35337002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 AY.4.2 variant circulating in Italy: Genomic preliminary insight.
    Angeletti S; Giovanetti M; Fogolari M; Cella E; De Florio L; Lintas C; Veralli R; Francesconi M; Caccuri F; De Cesaris M; De Flora C; Ceccarelli G; Spoto S; Caruso A; Pascarella S; Riva E; Ciccozzi M
    J Med Virol; 2022 Apr; 94(4):1689-1692. PubMed ID: 34766651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phylogeography and genomic analysis of SARS-CoV-2 delta variant in Morocco.
    El Mazouri S; Bendani H; Boumajdi N; Aanniz T; Kandoussi I; Amzazi S; Belyamani L; Ibrahimi A; Ouadghiri M
    J Infect Dev Ctries; 2022 Aug; 16(8):1258-1268. PubMed ID: 36099368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes from Delta AY.4.2: Cohort and test-negative study of 5.4 million individuals in Scotland.
    Kerr S; Vasileiou E; Robertson C; Sheikh A
    J Glob Health; 2022 Jul; 12():05025. PubMed ID: 35802764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.